Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 49 min ago
PreprintAll rights reservedbioRxiv

Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study

  1. 1RI-MUHC

Related

  1. Marked Response to Nivolumab Plus Ipilimumab After the Failure of Two Prior Immune Checkpoint Inhibitor–Based Regimens Including CTLA-4 Blockade in Advanced Hepatocellular Carcinoma
    Shinichiro Minami, Wataru Sato, Kenjiro Yamamoto +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE
  2. MYC Suppresses Mitochondrial Function in Hepatocellular Carcinoma through NRF1-Driven Receptor-Mediated Mitophagy
    N. P. Lesner, L. C. Kim, S. D. Shelton +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Hepatic arterial infusion chemotherapy plus lenvatinib and programmed death receptor 1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombosis: a prospective controlled study
    Kanglian Zheng, Ming Liu, Xu Zhu +17
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
  4. Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.
    Jin Li, Jin-Yi Zhou, Yue Yu +11
    Journal of hepatocellular carcinomaPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  5. Low CT-derived vertebral attenuation as a prognostic factor in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
    Shanshan Jiang, Yi Ren, Yuyang Wang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
BibTeX
@misc{leo2026novel,
  title = {{Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study}},
  author = {S. Leo and I. Dhoparee-Doomah and S. Negi and A. Fouda and F. Bourdeau and G. Evaristo and S. Paraskevas and J. Cools-Lartigue and J. Tchervenkov},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.13.758999},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.13.758999v1},
}
RIS
TY  - UNPB
TI  - Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
AU  - S. Leo
AU  - I. Dhoparee-Doomah
AU  - S. Negi
AU  - A. Fouda
AU  - F. Bourdeau
AU  - G. Evaristo
AU  - S. Paraskevas
AU  - J. Cools-Lartigue
AU  - J. Tchervenkov
PY  - 2026
DA  - 2026/10/13
PB  - bioRxiv
DO  - 10.64898/2026.10.13.758999
UR  - https://www.biorxiv.org/content/10.64898/2026.10.13.758999v1
ER  -